Peter W M Johnson Selected Research

Cytokines

4/2023

Obesity Is Associated with Immunometabolic Changes in Adipose Tissue That May Drive Treatment Resistance in Breast Cancer: Immune-Metabolic Reprogramming and Novel Therapeutic Strategies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter W M Johnson Research Topics

Disease

33	Neoplasms (Cancer) 10/2023 - 09/2002
22	Lymphoma (Lymphomas) 12/2023 - 09/2002
18	Hodgkin Disease (Hodgkin's Disease) 10/2023 - 12/2005
13	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 01/2003
7	Breast Neoplasms (Breast Cancer) 04/2023 - 08/2003
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 10/2017
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2017 - 03/2006
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 05/2017 - 09/2011
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2016 - 09/2011
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023
1	Inflammation (Inflammations) 04/2023
1	Obesity 04/2023
1	Overweight 04/2023
1	Carcinoma (Carcinomatosis) 01/2022
1	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021
1	COVID-19 01/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Dementia (Dementias) 01/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2021
1	Lymphocytosis 06/2015
1	Thrombosis (Thrombus) 01/2012
1	Febrile Neutropenia 01/2012
1	Sepsis (Septicemia) 01/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2012

Drug/Important Bio-Agent (IBA)

11	Rituximab (Mabthera)FDA Link 01/2023 - 02/2009
8	Proteins (Proteins, Gene)FDA Link 10/2023 - 09/2002
7	Monoclonal AntibodiesIBA 12/2017 - 02/2003
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2005
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 02/2016
4	Dacarbazine (DIC)FDA LinkGeneric 10/2018 - 12/2005
4	Bleomycin (Blenoxane)FDA LinkGeneric 10/2018 - 12/2005
4	Vinblastine (Vinblastine Sulfate)FDA Link 10/2018 - 12/2005
3	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 07/2016
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2002
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2017 - 06/2014
2	ibrutinibIBA 10/2023 - 05/2017
2	Trastuzumab (Herceptin)FDA Link 04/2023 - 01/2022
2	Prednisolone (Predate)FDA LinkGeneric 01/2023 - 11/2016
2	Bortezomib (Velcade)FDA Link 01/2023 - 01/2019
2	VaccinesIBA 01/2022 - 01/2021
2	AntigensIBA 01/2022 - 11/2018
2	Immunoglobulin G (IgG)IBA 11/2018 - 08/2014
2	AntibodiesIBA 11/2018 - 04/2015
2	varlilumabIBA 11/2018 - 12/2017
2	Histone Deacetylase InhibitorsIBA 05/2011 - 08/2008
2	Histone Deacetylases (Histone Deacetylase)IBA 05/2011 - 08/2008
1	parsaclisibIBA 12/2023
1	selinexorIBA 10/2023
1	maximum cureIBA 06/2023
1	CytokinesIBA 04/2023
1	AdipokinesIBA 04/2023
1	Hormones (Hormone)IBA 04/2023
1	Metformin (Glucophage)FDA LinkGeneric 04/2023
1	Aromatase (CYP19)IBA 04/2023
1	LeptinIBA 04/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2022
1	obinutuzumabIBA 01/2022
1	venetoclaxIBA 01/2020
1	PLX51107IBA 01/2020
1	BenzodiazepinesIBA 01/2020
1	GSK-2816126IBA 12/2019
1	Enhancer of Zeste Homolog 2 ProteinIBA 12/2019
1	Blocking AntibodiesIBA 12/2018
1	Immunoconjugates (Immunoconjugate)IBA 12/2018
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 11/2018
1	Janus Kinase InhibitorsIBA 05/2017
1	4- (cyclopropylamino)- 2- ((4- (4- (ethylsulfonyl)piperazin- 1- yl)phenyl)amino)pyrimidine- 5- carboxamideIBA 05/2017
1	Phosphotransferases (Kinase)IBA 05/2017
1	Prednisone (Sone)FDA LinkGeneric 07/2016
1	Etoposide (VP 16)FDA LinkGeneric 07/2016
1	Procarbazine (Matulane)FDA Link 07/2016
1	ibritumomab tiuxetan (Zevalin)FDA Link 04/2016
1	fludarabineIBA 02/2016
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 06/2015
1	IpilimumabIBA 08/2014
1	AnthracyclinesIBA 06/2014
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2012
1	Carboplatin (JM8)FDA LinkGeneric 01/2012
1	3-deazaadenosineIBA 05/2011
1	neplanocin AIBA 05/2011
1	3-deazaneplanocinIBA 05/2011
1	trichostatin A (A 300)IBA 05/2011
1	theasinensin AIBA 05/2011
1	AdenosylhomocysteinaseIBA 05/2011

Therapy/Procedure

26	Therapeutics 10/2023 - 09/2002
13	Drug Therapy (Chemotherapy) 06/2023 - 01/2008
7	Radiotherapy 06/2023 - 07/2010
3	Radioimmunotherapy 04/2016 - 02/2004
2	Immunotherapy 04/2023 - 08/2006
2	Precision Medicine 06/2021 - 10/2017
1	Salvage Therapy 01/2022
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2021
1	Kidney Transplantation 01/2021
1	Organ Transplantation 01/2021
1	Chemoradiotherapy 12/2018
1	Ligation 05/2013
1	Combination Drug Therapy (Combination Chemotherapy) 01/2013